STAT+: Eli Lilly ends 340B drug discounts to some hospitals for failing to provide claims data

Making good on its threat, Eli Lilly has begun eliminating mandated price breaks to a few dozen hospitals that participate in a federal drug discount program.

CryptoAlerta — análise de criptomoedas e mercado em tempo real